The role of probiotics in vaginal health
- PMID: 35967876
- PMCID: PMC9366906
- DOI: 10.3389/fcimb.2022.963868
The role of probiotics in vaginal health
Abstract
Probiotics have been widely used in the treatment of intestinal diseases, but the effect of probiotics on female reproductive tract health is still controversial. Lactobacillus is the most abundant microorganism in the vagina, which is related to the vaginal mucosal barrier. Lactobacillus adheres to the vaginal epithelium and can competitively antagonize the colonization of pathogens. The factors produced by Lactobacillus, such as bacteriocin and hydrogen peroxide (H2O2), can inhibit the growth of pathogenic microorganisms and maintain the low pH environment of the vagina. Probiotics play an important role in maintaining the stability of vaginal microenvironment, improving immune defense and blocking the progression of cervical cancer. We review the research progress of probiotics represented by Lactobacillus in gynecological diseases such as human papilloma virus (HPV) infection, bacterial vaginosis (BV) and Genitourinary Syndrome of Menopause (GSM), so as to provide basis for further exerting the role of probiotics in women's health.
Keywords: human papilloma virus; lactobacillus; probiotic; vaginal health; vaginal microenvironment.
Copyright © 2022 Mei and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Probiotics in vaginal health.Pathog Dis. 2023 Jan 17;81:ftad012. doi: 10.1093/femspd/ftad012. Pathog Dis. 2023. PMID: 37286796
-
The role of lactobacilli and probiotics in maintaining vaginal health.Arch Gynecol Obstet. 2014 Mar;289(3):479-89. doi: 10.1007/s00404-013-3064-9. Epub 2013 Oct 30. Arch Gynecol Obstet. 2014. PMID: 24170161 Review.
-
Exploring of probiotic potential vaginal lactobacillus isolates from healthy women against Gardnerella vaginalis and Caenorhabditis elegans model testing.J Appl Microbiol. 2022 Sep;133(3):1392-1401. doi: 10.1111/jam.15643. Epub 2022 Jun 7. J Appl Microbiol. 2022. PMID: 35633296
-
An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.BMC Infect Dis. 2019 Sep 18;19(1):824. doi: 10.1186/s12879-019-4425-1. BMC Infect Dis. 2019. PMID: 31533663 Free PMC article. Clinical Trial.
-
Mechanistic insights into the action of probiotics against bacterial vaginosis and its mediated preterm birth: An overview.Microb Pathog. 2020 Apr;141:104029. doi: 10.1016/j.micpath.2020.104029. Epub 2020 Jan 31. Microb Pathog. 2020. PMID: 32014462 Review.
Cited by
-
Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions.MedComm (2020). 2023 Sep 14;4(5):e368. doi: 10.1002/mco2.368. eCollection 2023 Oct. MedComm (2020). 2023. PMID: 37719443 Free PMC article. Review.
-
Use of probiotic lactobacilli in the treatment of vaginal infections: In vitro and in vivo investigations.Front Cell Infect Microbiol. 2023 Apr 3;13:1153894. doi: 10.3389/fcimb.2023.1153894. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37077531 Free PMC article. Review.
-
Does "all disease begin in the gut"? The gut-organ cross talk in the microbiome.Appl Microbiol Biotechnol. 2024 May 21;108(1):339. doi: 10.1007/s00253-024-13180-9. Appl Microbiol Biotechnol. 2024. PMID: 38771520 Free PMC article. Review.
-
Preclinical Potential of Probiotic-Loaded Novel Gelatin-Oil Vaginal Suppositories: Efficacy, Stability, and Safety Studies.Gels. 2023 Mar 19;9(3):244. doi: 10.3390/gels9030244. Gels. 2023. PMID: 36975693 Free PMC article.
-
Vaccine Strategies to Elicit Mucosal Immunity.Vaccines (Basel). 2024 Feb 13;12(2):191. doi: 10.3390/vaccines12020191. Vaccines (Basel). 2024. PMID: 38400174 Free PMC article. Review.
References
-
- Abdolalipour E., Mahooti M., Salehzadeh A., Torabi A., Mohebbi S. R., Gorji A., et al. . (2020). Evaluation of the antitumor immune responses of probiotic bifidobacterium bifidum in human papillomavirus-induced tumor model. Microb. Pathog. 145, 104207. doi: 10.1016/j.micpath.2020.104207 - DOI - PubMed
-
- Anukam K., Osazuwa E., Ahonkhai I., Ngwu M., Osemene G., Bruce A. W., et al. . (2006). Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic lactobacillus rhamnosus GR-1 and lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect. 8 (6), 1450–1454. doi: 10.1016/j.micinf.2006.01.003 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources